UBS downgraded Westlake Chemical from Buy to Neutral and set a new price target of $25.00 from $23.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/2/2022 | $30.00 → $31.00 | Buy | Deutsche Bank |
| 7/16/2021 | $27.00 | Buy → Underperform | BofA Securities |
10-Q - Westlake Chemical Partners LP (0001604665) (Filer)
8-K - Westlake Chemical Partners LP (0001604665) (Filer)
8-K - Westlake Chemical Partners LP (0001604665) (Filer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4/A - Westlake Chemical Partners LP (0001604665) (Issuer)
Declared quarterly distribution of $0.4714 per unit; 47th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the first quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was above first quarter 2025 net income of $4.9 million. Cash flows from operating activities in the first quarter of 2026 were $110.2 million, an increase of $64.4 million compared to first quarter 2025 cash flows from operating activities of $45.8 million, due to higher production and sales volume as the result of the prior year's Petro 1 turnaround. For the three months ended March 31, 20
$0.4714 per unit distribution declared payable on June 1, 2026 The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 47th quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on June 1, 2026, to unit holders of record on May 14, 2026. This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributabl
Westlake Chemical Partners (NYSE:WLKP) will release its first quarter 2026 earnings prior to the market opening on Tuesday, May 5, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI15886588e6004070bc18c354348f7575. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/493g3eiw and th
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4/A - Westlake Chemical Partners LP (0001604665) (Issuer)
Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously
BofA Securities downgraded Westlake Chemical Partners from Buy to Underperform and set a new price target of $27.00
UBS downgraded Westlake Chemical from Buy to Neutral and set a new price target of $25.00 from $23.00 previously
Declared quarterly distribution of $0.4714 per unit; 47th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the first quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was above first quarter 2025 net income of $4.9 million. Cash flows from operating activities in the first quarter of 2026 were $110.2 million, an increase of $64.4 million compared to first quarter 2025 cash flows from operating activities of $45.8 million, due to higher production and sales volume as the result of the prior year's Petro 1 turnaround. For the three months ended March 31, 20
Westlake Chemical Partners (NYSE:WLKP) will release its first quarter 2026 earnings prior to the market opening on Tuesday, May 5, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI15886588e6004070bc18c354348f7575. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/493g3eiw and th
Strong fourth quarter coverage ratio of 1.13x following the completion of the Petro 1 turnaround Declared quarterly distribution of $0.4714 per unit; 46th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2025 of $14.5 million, or $0.41 per limited partner unit, which was relatively in line with fourth quarter 2024 net income of $15.0 million. Cash flows from operating activities in the fourth quarter of 2025 were $120.4 million, a decrease of $12.1 million compared to fourth quarter 2024 cash flows from operating activities of $132.5 million, due to lower
SC 13D/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") announced today that Mr. Jonathan H. Baksht will be joining the Partnership as Senior Vice President and Chief Financial Officer and as a director of Westlake Chemical Partners GP LLC, the general partner of the Partnership (the "General Partner"), effective June 15, 2026. Mr. Baksht succeeds Mr. M. Steven Bender, who, as previously disclosed, will retire by the end of the year and, effective June 15, 2026, will retire from the Board of Directors of the General Partner and transition from his position as Executive Vice President and Chief Financial Officer of the General Partner to the position of Special Advisor to the President
Westlake Chemical Partners (NYSE:WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed the company that she would resign from the board effective upon the appointment of her successor. Ms. Friel was the Managing Partner of Ernst & Young LLP's San Antonio, Texas office from July 2012 until her retirement in September 2020. Ms. Friel began her career with Ernst & Young LLP in 1988. She is currently the Chair of the Board of Directors for the United Way of San Antonio. Ms. Friel holds a bachelor's of science degree in Accounting and Busi
Retirement of Dr Sarah Ryan and Dr Christopher Haynes from the Woodside BoardPERTH, AUSTRALIA / ACCESSWIRE / March 8, 2023 / The Board of Woodside announces the retirement of Dr Sarah Ryan and Dr Christopher Haynes as Directors of Woodside. Dr Ryan and Dr Haynes will be standing down from their respective offices with effect from the conclusion of Woodside's 2023 Annual General Meeting, scheduled to be held on 28 April 2023 (2023 AGM).Dr Haynes has served on Woodside's Board since 2011 and is a member of the Audit & Risk Committee, the Sustainability Committee and the Nominations & Governance Committee.Dr Ryan joined the Woodside Board in December 2012 and serves on the Audit & Risk Committe